Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 20 Week Double-Blind Randomized Trial of Clomiphene Citrate and Letrozole for the Treatment of Infertility in Women With Polycystic Ovary Syndrome

Trial Profile

A 20 Week Double-Blind Randomized Trial of Clomiphene Citrate and Letrozole for the Treatment of Infertility in Women With Polycystic Ovary Syndrome

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clomifene (Primary) ; Letrozole (Primary)
  • Indications Female infertility; Hyperandrogenism; Polycystic ovary syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PPCOSII
  • Most Recent Events

    • 11 Apr 2021 Results assessing the associations of Metabolic syndrome with ovulation induction live birth rate and pregnancy complications in obese women with PCOS, and to see if these outcomes differ by specific agent used for ovulation induction, published in the American Journal of Obstetrics and Gynecology
    • 31 Aug 2020 Results (N=264), of secondary analysis were participants from PPCOS II and AMIGOS assessing the relationship between high antimullerian hormone (AMH) levels and increased preterm delivery risk in populations of women with polycystic ovary syndrome or unexplained infertility undergoing ovulation induction, published in the Fertility and Sterility
    • 05 Aug 2020 Results assessing association of BMI ith reduced AMH in PCOS and ovulatory controls (OVA) and the reduction of AMH, published in the Journal of Clinical Endocrinology and Metabolism.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top